(Q35552356)

8 August 2017

1 reference

title

Ovarian cancer and high-risk women-implications for prevention, screening, and early detection (English)

1 reference

8 August 2017

Ovarian cancer and high-risk women—implications for prevention, screening, and early detection (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

18 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

18 March 2024

1

Francesmary Modugno

1 reference

8 August 2017

author name string

Ovarian Cancer and High-Risk Women Symposium Presenters

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0090825803002543?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

https://api.elsevier.com/content/article/PII:S0090825803002543?httpAccept=text/plain

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

18 March 2024

1 reference

8 August 2017

volume

91

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

15-31

1 reference

Genetic epidemiology of ovarian cancer: segregation analysis

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Genetics of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Early detection research program at the NCI.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Classification of human ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The epidemiology of ovarian cancer in Greece: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The woman at risk for developing ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risk factors for ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

An epidemiologic study of epithelial carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

"Incessant ovulation" and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Epithelial ovarian cancer and combination oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Case-control study of ovarian cancer in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Reproductive factors and risk of ovarian cancer: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

An epidemiologic study of the relationship of reproductive experience to cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risk factors for epithelial ovarian cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

An epidemiologic case-control study of ovarian cancer and reproductive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Events of reproductive life and the incidence of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The influence of age at first birth and parity on ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Epidemiology of cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Reproductive, genetic, and dietary risk factors for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptives and neoplasia of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incidence of the histologic types of ovarian cancer: the U.S. Third National Cancer Survey, 1969-1971.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incidence of ovarian cancer in relation to the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A case-control study of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Factors affecting the association of oral contraceptives and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptives and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The genetic attributable risk of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Contribution of BRCA1 mutations to ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Growth retardation and tumour inhibition by BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Reduction of BRCA1 expression in sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Emerging roles of BRCA1 in transcriptional regulation and DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incessant ovulation--a factor in ovarian neoplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Menopause and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Hormone replacement therapy and risk of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Noncontraceptive estrogen use and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Cancer risk after evaluation for infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian tumors in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Multiple births and risk of epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Beyond ovulation: oral contraceptives and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Possible role of ovarian epithelial inflammation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Metabolism of androstenedione by human ovarian tissues ? ? with particular reference to reductase and aromatase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Effect of oral contraceptives on plasma testosterone concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Serum gonadotropins and steroid hormones and the development of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Anthropometry and breast cancer. Body size--a moving target

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Associations of Body Mass and Fat Distribution with Sex Hormone Concentrations in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Serum testosterone fractions in women: normal and abnormal clinical states.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Dehydroepiandrosterone sulfate and testosterone are independently associated with body fat distribution in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Biology of female sex hormone action in relation to contraceptive agents and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A case-control study of oral contraceptive use and invasive epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Perineal powder exposure and the risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian cancer and talc: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Genital talc exposure and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prospective study of talc use and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Tubal ligation and fatal ovarian cancer in a large prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Surgical procedures associated with risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Cancer risk after a hospital discharge diagnosis of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Over-the-counter analgesics and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Aspirin and ovarian cancer: An Italian case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Aspirin and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Pathogenesis of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ultrastructural epithelial zonation of the primate endometrium (rhesus monkey).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian tumors of the hen.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Effect of fenretinide on ovarian carcinoma occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Retinoids and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The Choice of Animal Tumors for Experimental Studies of Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian neoplasia in the Sprague-Dawley rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of a 7,12-dimethylbenz[a]anthracene-coated suture: common epithelial tumors of the ovary in rats?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Induction of Sertoli cell tumors in the rat ovary by N-alkyl-N-nitrosoureas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The Induction of Ovarian Tumours in Mice with 9: 10-Dimethyl-1: 2-Benzanthracene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Nonneoplastic lesions of the ovary in Fischer 344 rats and B6C3F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Development of a syngeneic mouse model for events related to ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Immunohistochemical analysis of the microanatomy of primate ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Pathological findings in condemned chickens: a survey of 1,000 carcases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ultrasound screening for familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian surface epithelium: biology, endocrinology, and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovulation and the role of the ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Reciprocal Interactions between Human Ovarian Surface Epithelial Cells and Adjacent Extracellular Matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A line of rat ovarian surface epithelium provides a continuous source of complex extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The CA 125 tumour-associated antigen: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Molecular aspects of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Tumour suppressor genes in sporadic epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Role of the p16 tumor suppressor gene in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

c-myc amplification in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Precursor lesions of ovarian epithelial malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

A genetic epidemiological study of carcinoma of the fallopian tube

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Menopause and the risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Influence of bilateral oophorectomy upon lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Incidence of sexual dysfunction in surgically menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Elective ovarian removal and estrogen replacement therapy--effects on sexual life, psychological well-being and androgen status.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Psychological reactions and sexual life after hysterectomy with and without oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Sex, hormones, and hysterectomies.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Is maternal obesity a risk factor for anencephaly and spina bifida?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900254-3

7 January 2021

Age at first birth and the risk of epithelial ovarian cancer

32

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

18 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Variation in BRCA1 cancer risks by mutation position

18 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

18 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?

18 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis

18 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Which hormone tests for the diagnosis of polycystic ovary syndrome?

18 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women

18 March 2024

114

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Sex hormone metabolism in upper and lower body obesity

18 March 2024

117

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Immunocytochemical versus biochemical receptor determination in normal and tumorous tissues of the female reproductive tract and the breast

18 March 2024

124

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Tubal ligation and the risk of ovarian carcinoma

18 March 2024

139

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives

18 March 2024

141

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Pelvic inflammatory disease and the risk of epithelial ovarian cancer

18 March 2024

144

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Regular use of analgesic drugs and ovarian cancer risk

18 March 2024

147

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

18 March 2024

156

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity

18 March 2024

172

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Morphology and classification of ovarian neoplasms in F344 rats and (C57BL/6 X C3H)F1 mice

18 March 2024

177

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

In vivo and in vitro studies of experimental ovarian adenocarcinoma in rats

18 March 2024

181

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Transplacental induction of gonadal tumors in rats by a nitrosamine

18 March 2024

182

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

The pathogenesis of ovarian inclusion cysts and cystomas

18 March 2024

214

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies

18 March 2024

223

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms

18 March 2024

230

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer

18 March 2024

245

1 reference

https://api.crossref.org/works/10.1016/S0090-8258(03)00254-3

18 March 2024

Identifiers

1 reference

release_ugsm5qn4trdyngym7anfm67r6e

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugsm5qn4trdyngym7anfm67r6e

24 November 2022

mapped directly with Wikidata item

1 reference